UMedic has prospective earnings growth over the next two years


UMediC Group Bhd's manufacturing plant in Batu Kawan, Penang.

PETALING JAYA: Rakuten Trade Sdn Bhd has placed a “buy” call on medical device maker UMediC Group Bhd with a higher target price (TP) of 90 sen from 76 sen.

In a report, the research house said the fast growing distributor of medical equipment and manufacturer of medical consumables is backed by solid prospective earnings growth over the next two years.

The Star 6.6 DEAL: 35% OFF Digital Access

Monthly Plan

RM 13.90/month

RM 9.04/month

Billed as RM 9.04 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 8.02/month

Billed as RM 96.20 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
UMedic

Next In Business News

Yuan brushes off dollar strength, trade data eyed
Supply crisis to push costs beyond oil prices, whole-of-nation response needed
How a few AI chip giants warped Asia's stock picking game
Bursa Malaysia falls at midday as regional sell-off weighs
Sirim appoints Nik Sazali Nik Hussin as president and group CEO
Maybank rolls out next-generation Maybank2E platform
Gas Malaysia advances energy security, resilience via partnership with�Tokyo Gas, VTTI
Nvidia clinches deals with South Korean giants include SK Group to advance AI boom
IATA: Middle East disruptions, high fuel prices to halve airline industry profitability in 2026
How can retail investors buy shares in SpaceX's IPO?

Others Also Read